OTC Obesity - Philippines

March 2010 | 34 pages | ID: OCEC0D3FE63EN
Euromonitor International Ltd

Abstracts

OTC obesity current value sales declined by 10% in 2009 to reach Ps343 million. Volume sales also declined by 10%. During the first half of the review period, demand for OTC obesity products grew strongly as many Filipinos, influenced by the mass media fixation on celebrities with slim and well-toned bodies, became increasingly figure conscious. For men and women alike, the advent of OTC obesity products provided a safer and cheaper alternative to liposuction and other weight loss treatments...

Euromonitor International's OTC Obesity Products in Philippines report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage:

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health industry;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

OTC Obesity in the Philippines
Euromonitor International
March 2010

LIST OF CONTENTS AND TABLES

Executive Summary
Economic Downturn Slows the Development of Consumer Healthcare
More Filipinos Turn To Preventive Healthcare and Self-medication in 2009
United Laboratories Inc Remains the Clear Leader in Consumer Healthcare
Parapharmacies/drugstores and Chemists/pharmacies Dominate Distribution
Sluggish Market Development Predicted Over the Forecast Period
Key Trends and Developments
Economic Crisis and Swine Flu Fears Strengthen Preventive Healthcare Trend
Filipinos Place An Increasingly High Priority on Physical Appearance
Reductions in Marketing Budgets Slow the Development of Several Categories
the Cheaper Medicines Law Comes Into Effect in 2009
Herbal/traditional Products Gain Popularity in 2009
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
De-listing Or De-reimbusement
Bioequivalents/generics
Combination Products
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Combination Products
Advertising
Packaging and Labelling
Distribution
Self-medication/self-care and Preventative Medicine
Switches
Definitions
  Summary 1 Research Sources
International Pharmaceuticals Inc
Strategic Direction
Key Facts
  Summary 2 International Pharmaceuticals Inc: Key Facts
  Summary 3 International Pharmaceuticals Inc: Operational Indicators 2007-2008
Company Background
Production
Competitive Positioning
  Summary 4 International Pharmaceuticals Inc: Competitive Position 2009
Macropharma Corp
Strategic Direction
Key Facts
  Summary 5 Macropharma Corp: Key Facts
Company Background
Production
Competitive Positioning
  Summary 6 Macropharma Corp: Competitive Position 2009
Pascual Laboratories Inc
Strategic Direction
Key Facts
  Summary 7 Pascual Laboratories Inc: Key Facts
  Summary 8 Pascual Laboratories Inc: Operational Indicators 2007-2008
Company Background
Production
Competitive Positioning
  Summary 9 Pascual Laboratories Inc: Competitive Position 2009
Philusa Corp
Strategic Direction
Key Facts
  Summary 10 Philusa Corp: Key Facts
Company Background
Competitive Positioning
  Summary 11 Philusa Corp: Competitive Position 2009
United Laboratories Inc
Strategic Direction
Key Facts
  Summary 12 United Laboratories Inc: Key Facts
  Summary 13 United Laboratories Inc: Operational Indicators 2007-2008
Company Background
Production
Competitive Positioning
  Summary 14 United Laboratories Inc: Competitive Position 2009
Trends
Category Data
  Table 11 Sales of OTC Obesity: Value 2005-2009
  Table 12 Sales of OTC Obesity: % Value Growth 2005-2009
  Table 13 OTC Obesity Company Shares by Value 2005-2009
  Table 14 OTC Obesity Brand Shares by Value 2006-2009
  Table 15 Forecast Sales of OTC Obesity: Value 2009-2014
  Table 16 Forecast Sales of OTC Obesity: % Value Growth 2009-2014